Key Developments in the Management of Melanoma: Current Combinations, Therapies in Development, and Sequencing Considerations
This educational enduring program will help healthcare professionals to optimize patient outcomes for those with advanced melanoma without actionable melanoma mutations. Specifically, the programming will improve clinicians’ knowledge of the latest data concerning appropriate assessment of melanoma from a clinical pathologic view and familiarize them with current updates with single-agent and combination therapy in advanced melanoma across settings of care, while preparing them to best manage adverse events across these therapies.
RELEASED DATE: June 30, 2023
EXPIRATION DATE: June 30, 2024
